Company: GANX
Filing Date: 2025-04-17
Form Type: PRE 14A
Source: 0001558370-25-004958
Chunk: 36

Company: Gain Therapeutics, Inc.
Filing Date: 2025-04-17
Form: PRE 14A
Chunk 36
---
. Mack’s elevation to Chief Executive Officer as of January 6, 2025, Mr. Fuggetta was appointed Senior Vice President Finance and Principal Financial Officer. |

| (9) | Mr. Fuggetta received an annual base salary of ₣180,000 and non-equity incentive plan compensation of ₣21,000, which for reporting purposes has been converted into U.S. dollars at the 2024 average exchange rate of $1.136. Mr. Fuggetta received no additional compensation for his role as Principal Financial Officer from February 21, 2024 to April 5, 2024. |

| (10) | Mr. Fuggetta received an annual base salary of ₣150,000 and non-equity incentive plan compensation of ₣9,750, which for reporting purposes has been converted into U.S. dollars at the 2023 average exchange rate of $1.114. |

| (11) | Mr. Alder served as our Chief Executive Officer from September 20, 2022 until June 25, 2024. |

| (12) | Amount reflects an annual base salary of $525,000 pro-rated for Mr. Alder’s time as Chief Executive Officer from January 1, 2024 through June 25, 2024. |

| (13) | A portion of Mr. Alder’s stock awards were forfeited upon his termination from employment with the Company on June 25, 2024. |

| (14) | A portion of Mr. Alder’s option awards were forfeited upon his termination from employment with the Company on June 25, 2024. |

| (15) | Mr. Ballantyne served as our Chief Financial Officer from April 10, 2023 until March 1, 2024. |

| (16) | Amount reflects an annual base salary of $350,000 pro-rated for Mr. Ballantyne’s time as Chief Financial Officer from January 1, 2024 through March 1, 2024. |

| (17) | Mr. Ballantyne’s stock awards were forfeited upon his resignation from employment with the Company on March 1, 2024. |

| (18) | Mr. Ballantyne’s option awards were forfeited upon his resignation from employment with the Company on March 1, 2024. |

| (19) | Amount reflects an annual base